These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25732373)

  • 1. Sublingual Diffusion of Epinephrine Microcrystals from Rapidly Disintegrating Tablets for the Potential First-Aid Treatment of Anaphylaxis: In Vitro and Ex Vivo Study.
    Rawas-Qalaji MM; Werdy S; Rachid O; Simons FE; Simons KJ
    AAPS PharmSciTech; 2015 Oct; 16(5):1203-12. PubMed ID: 25732373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenaline (epinephrine) microcrystal sublingual tablet formulation: enhanced absorption in a preclinical model.
    Rawas-Qalaji M; Rachid O; Mendez BA; Losada A; Simons FE; Simons KJ
    J Pharm Pharmacol; 2015 Jan; 67(1):20-5. PubMed ID: 25256073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Evaluation of Taste-Masked Fast-Disintegrating Sublingual Tablets of Epinephrine Microcrystals.
    Rachid O; Simons KJ; Rawas-Qalaji M
    AAPS PharmSciTech; 2018 Nov; 19(8):3886-3894. PubMed ID: 30324360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidly-disintegrating sublingual tablets of epinephrine: role of non-medicinal ingredients in formulation development.
    Rachid O; Rawas-Qalaji M; Simons FE; Simons KJ
    Eur J Pharm Biopharm; 2012 Nov; 82(3):598-604. PubMed ID: 22683694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is epinephrine administration by sublingual tablet feasible for the first-aid treatment of anaphylaxis? A proof-of-concept study.
    Gu X; Simons KJ; Simons FE
    Biopharm Drug Dispos; 2002 Jul; 23(5):213-6. PubMed ID: 12116053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of epinephrine sublingual stability and permeability pathways to enhance its permeability for the treatment of anaphylaxis.
    Rawas-Qalaji M; Bafail R; Cagliani R; Haider M; Hussain Z
    Eur J Pharm Sci; 2021 Dec; 167():106025. PubMed ID: 34600046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epinephrine in Anaphylaxis: Preclinical Study of Pharmacokinetics after Sublingual Administration of Taste-Masked Tablets for Potential Pediatric Use.
    Rachid O; Rawas-Qalaji M; Simons KJ
    Pharmaceutics; 2018 Feb; 10(1):. PubMed ID: 29439456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis.
    Rawas-Qalaji MM; Simons FE; Simons KJ
    J Allergy Clin Immunol; 2006 Feb; 117(2):398-403. PubMed ID: 16461140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term stability of epinephrine sublingual tablets for the potential first-aid treatment of anaphylaxis.
    Rawas-Qalaji MM; Rachid O; Simons FE; Simons KJ
    Ann Allergy Asthma Immunol; 2013 Dec; 111(6):568-70. PubMed ID: 24267371
    [No Abstract]   [Full Text] [Related]  

  • 10. Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.
    Rawas-Qalaji MM; Simons FE; Simons KJ
    AAPS PharmSciTech; 2006 Apr; 7(2):E41. PubMed ID: 16796358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
    Freag MS; Elnaggar YS; Abdallah OY
    Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epinephrine for the treatment of anaphylaxis: do all 40 mg sublingual epinephrine tablet formulations with similar in vitro characteristics have the same bioavailability?
    Rawas-Qalaji MM; Simons FE; Simons KJ
    Biopharm Drug Dispos; 2006 Dec; 27(9):427-35. PubMed ID: 17009337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epinephrine auto-injectors: first-aid treatment still out of reach for many at risk of anaphylaxis in the community.
    Simons FE;
    Ann Allergy Asthma Immunol; 2009 May; 102(5):403-9. PubMed ID: 19492662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
    Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-aid treatment of anaphylaxis to food: focus on epinephrine.
    Simons FE
    J Allergy Clin Immunol; 2004 May; 113(5):837-44. PubMed ID: 15131564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epinephrine (adrenaline) in the first-aid, out-of-hospital treatment of anaphylaxis.
    Simons FE
    Novartis Found Symp; 2004; 257():228-43; discussion 243-7, 276-85. PubMed ID: 15025402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fast-disintegrating sublingual epinephrine tablets: effect of tablet dimensions on tablet characteristics.
    Rawas-Qalaji MM; Simons FE; Simons KJ
    Drug Dev Ind Pharm; 2007 May; 33(5):523-30. PubMed ID: 17520443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel vesicular transdermal delivery of nifedipine - preparation, characterization and in vitro/in-vivo evaluation.
    Yasam VR; Jakki SL; Natarajan J; Venkatachalam S; Kuppusamy G; Sood S; Jain K
    Drug Deliv; 2016; 23(2):619-30. PubMed ID: 25005581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characterization and invivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles.
    Dhana Lekshmi UM; Poovi G; Kishore N; Reddy PN
    Int J Pharm; 2010 Aug; 396(1-2):194-203. PubMed ID: 20600729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Fast-Disintegrating Tablets' Characteristics on the Sublingual Permeability of Atropine Sulfate for the Potential Treatment of Organophosphates Toxicity.
    Aodah A; Rawas-Qalaji M; Bafail R; Rawas-Qalaji M
    AAPS PharmSciTech; 2019 Jun; 20(6):229. PubMed ID: 31227930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.